MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
3.490
+0.160 (4.80%)
Nov 20, 2024, 4:00 PM EST - Market closed
MaxCyte Employees
MaxCyte had 143 employees as of December 31, 2023. The number of employees increased by 18 or 14.40% compared to the previous year.
Employees
143
Change (1Y)
18
Growth (1Y)
14.40%
Revenue / Employee
$318,874
Profits / Employee
-$249,902
Market Cap
349.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enhabit | 10,800 |
ZimVie | 2,600 |
Ginkgo Bioworks Holdings | 1,218 |
Valneva SE | 676 |
Amylyx Pharmaceuticals | 384 |
Kamada | 378 |
Alector | 244 |
Omeros | 198 |
MXCT News
- 8 days ago - MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics - GlobeNewsWire
- 14 days ago - MaxCyte, Inc. (MXCT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance - GlobeNewsWire
- 21 days ago - MaxCyte to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - MaxCyte Appoints Cynthia Collins to its Board of Directors - GlobeNewsWire
- 5 weeks ago - MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 6 weeks ago - MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer - GlobeNewsWire
- 6 weeks ago - Maxcyte: Reaching Financial Inflection With CASGEVY Ramp Up - Seeking Alpha